CHATTANOOGA, Tenn. (August 25, 2021) – The Austin Hatcher Foundation for Pediatric Cancer (AHFPC) recently hosted Dr. Robert Noll, Ph.D. for his Bright IDEAS Problem Solving Skills Training.
The Austin Hatcher Foundation’s clinical staff consists of a Licensed Clinical Social Worker, a Licensed Clinical Psychologist, a Licensed Occupational Therapist and Clinical Director, a Clinical Liaison and a Child and Family Service Coordinator. All members of the clinical staff were included in the Bright IDEAS training that was held at the foundation’s Education Advancement Center on July 30, 2021.
Bright IDEAS is an evidence-based cognitive behavioral therapy designed to help develop constructive coping skills in caregivers of children recently diagnosed with cancer. This training program has been found to be more effective in alleviating distress than treatment as usual or non-directive supportive therapy. Because it is a skills-based intervention, its benefits persist and may be enhanced over time.
Dr. Robert Noll, Ph.D. is a Professor of Pediatrics, Psychiatry, and Psychology in the School of Medicine at the University of Pittsburgh. Over the past 25 years, Dr. Noll’s research has focused on psychosocial issues in pediatric oncology, leading to developing new evidence-based interventions.
The Austin Hatcher Foundation for Pediatric Cancer provides free, specialized therapies to families that have been impacted by childhood cancer. All members of the family are able to receive therapies to cope with their immediate needs in the present and help them thrive in the future. The foundation plans to use the Bright IDEAS training to provide effective intervention for any of the families that are seen at the foundation.
“We are so honored to have hosted Dr. Noll at our Education Advancement Center for his Bright IDEAS training,” said foundation President, Amy Jo Osborn. “Our staff receiving this training is another example of the foundation’s commitment to growth and continuing to provide the best care for patients and families impacted by pediatric cancer.”